期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
How Well Informed of Participants in Clinical Trials: A Case Study of China
1
作者 yutong jiang Zhifan Huang +4 位作者 Lei Chen Yukang Cui Hong Zhu Tongjun Shi Zaixiang Tan 《International Journal of Clinical Medicine》 2022年第4期167-179,共13页
Background: With the development of globalization, the rising cost of clinical trials in Europe and the United States, and the huge drug consumption market in developing countries, multinational pharmaceutical giants ... Background: With the development of globalization, the rising cost of clinical trials in Europe and the United States, and the huge drug consumption market in developing countries, multinational pharmaceutical giants have set their sights on emerging developing countries. As a leader in developing countries, China has unparalleled advantages, so more and more clinical trials are registered and carried out in China. Objective: The objective of the study is to understand the current practice of informed consent in clinical trials in public hospitals in Xuzhou. Methods: In this study, a 15-question questionnaire was distributed to 369 subjects in the affiliated hospital of Xuzhou medical university. Each question was graded on a 3-point scale (1 = no, 2 = unsure, 3 = yes). The sum of the scores for the 15 questions represented the level of awareness of clinical trials. Results: Valid questionnaires were received from 300 subjects. A considerable number of subjects still had insufficient understanding of clinical trials, especially concerning the nature of clinical trials, understanding of informed consent forms, contact with researchers, and ethics committee. (The “yes” rate was around or below 50%). Factors associated with responses to the survey include education, occupation, and source of medical expenses. Conclusion: Overall, this study showed that the implementation of informed consent in China remained room for improvement. Legislators, ethics officers, and researchers should work together to protect the interests of subjects. 展开更多
关键词 Clinical Trials Informed Consent Ethics-Research China
下载PDF
Efficient SO_(2)removal using aqueous ionic liquid at low partial pressure
2
作者 yutong jiang Yifeng Chen +4 位作者 Fuliu Yang Jixue Fan Jun Li Zhuhong Yang Xiaoyan Ji 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2023年第6期355-363,共9页
The development of novel absorbents is essential for SO_(2)removal.In this study,a novel ionic liquid(IL,[BHEP][HSO_(4)])was prepared,and water was selected as the co-solvent.The density and viscosity of aqueous[BHEP]... The development of novel absorbents is essential for SO_(2)removal.In this study,a novel ionic liquid(IL,[BHEP][HSO_(4)])was prepared,and water was selected as the co-solvent.The density and viscosity of aqueous[BHEP][HSO_(4)]were measured and the SO_(2)absorption performance was systematically investigated.Furthermore,the thermodynamic properties of SO_(2)in aqueous[BHEP][HSO_(4)]were calculated.Additionally,the mechanism of SO_(2)absorption in aqueous[BHEP][HSO_(4)]was confirmed using Fouriertransform infrared and nuclear magnetic resonance spectroscopy.It showed that[BHEP][HSO_(4)]absorbed0.302 g·g^(-1)(g SO_(2)/g IL)at an SO_(2)partial pressure of 2000μl·L^(-1)at 303.2 K,and the SO_(2)desorption enthalpy was-39.63 k J·mol^(-1).The mechanistic study confirmed the chemical absorption of SO_(2)in aqueous[BHEP][HSO_(4)]. 展开更多
关键词 Ionic liquids Sulfur dioxide Absorption capacity Desorption enthalpy
下载PDF
白蚁消化系统转化和降解木质纤维素酶研究进展 被引量:4
3
作者 蒋宇彤 张硕 +1 位作者 林子佳 倪金凤 《微生物学报》 CAS CSCD 北大核心 2020年第12期2635-2649,共15页
木质纤维素是地球上最丰富的有机聚合物,白蚁是古老但进化最成功的高效木质纤维素降解者之一。了解白蚁降解高度抗性植物聚合物的机制对工业上生物质能源转化和生物仿生设计有重要的借鉴和指导价值。白蚁和其共生微生物产生的木质纤维... 木质纤维素是地球上最丰富的有机聚合物,白蚁是古老但进化最成功的高效木质纤维素降解者之一。了解白蚁降解高度抗性植物聚合物的机制对工业上生物质能源转化和生物仿生设计有重要的借鉴和指导价值。白蚁和其共生微生物产生的木质纤维素酶在其转化利用木质纤维素上发挥着重要作用。本文从来源作用方面对白蚁自身及其肠道原虫、细菌和真菌产生的纤维素酶、木聚糖酶和漆酶等酶研究概况进行了总结,对其存在的问题和前景进行了展望。本综述有助于全面了解白蚁消化系统木质纤维素酶的基因种类、来源、分布、表达以及酶活性和功能。 展开更多
关键词 白蚁 木质纤维素降解 纤维素酶 木聚糖酶 漆酶
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部